1. In vitro evaluation of the cis-[Ru(phen) 2 (pPDIp)] 2+⁎⁎ complex for antimicrobial photodynamic therapy against Sporothrix brasiliensis and Candida albicans.
- Author
-
Tiburcio MA, Rocha AR, Romano RA, Inada NM, Bagnato VS, Carlos RM, and Buzzá HH
- Subjects
- Candida albicans radiation effects, Photosensitizing Agents pharmacology, Photosensitizing Agents therapeutic use, Anti-Infective Agents therapeutic use, Photochemotherapy methods, Sporothrix
- Abstract
Background: Photodynamic therapy (PDT) activates a photosensitizer by visible light to generate cytotoxic oxygen species that lead to cell death. With proper illumination, PDT is often used in applications on superficial and sub-surface lesions. Sporotrichosis infection occurs by Sporothrix fungi which causes a skin wound, worsened by Candida albicans infections. This study investigated the photosensitizing efficiency of the Ru(phen)
2 (pPDIp)(PF6 )2 complex, RupPDIp, against S. brasiliensis and C. albicans., Material and Methods: RupPDIp efficiency against these fungi was tested using 450 nm (blue light and 36 J/cm2 ) and 525 nm (green light, 25.2 J/cm2 ) at 0.05-20 μM concentrations. To ensure PDT effectiveness, control groups were tested in the absence and in the presence of RupPDIp under light irradiation and in the dark., Results: RupPDIp eliminated both fungi at ≤5.0 μM. Green light showed the best results, eliminating S. brasiliensis and C. albicans colonies at RupPDIp 0.5 μM and 0.05 μM, respectively., Conclusion: RupPDIp is a promising photosensitizer in aPDT, eliminating 106 CFU/mL of both fungi at 450 nm and 525 nm, with lower light doses and concentrations when treated with the green light compared to the blue light., (Copyright © 2022 Elsevier B.V. All rights reserved.)- Published
- 2022
- Full Text
- View/download PDF